PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today , to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) ("Sirtex"). Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is listed on the Australian Securities Exchange.
The conference call and webcast will start at 9:00 a.m. ET on Tuesday, January 30, 2018. To access the teleconference call and replay:
Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261.
Webcast: The live webcast and replay will be available on the Varian Investor Relations website at www.varian.com/investors .
About Varian
Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Investor Relations Contact
J. Michael Bruff
Vice President, Investor Relations
+1 (650) 424-5163
mike.bruff@varian.com
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
View original content: http://www.prnewswire.com/news-releases/varian-to-discuss-agreement-to-acquire-sirtex-300590021.html
SOURCE Varian